PARAMETRIC PORTFOLIO ASSOCIATES LLC - RIGEL PHARMACEUTICALS INC ownership

RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 142 filers reported holding RIGEL PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 1.79 and the average weighting 0.1%.

Quarter-by-quarter ownership
PARAMETRIC PORTFOLIO ASSOCIATES LLC ownership history of RIGEL PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$1,452,000
+222.0%
485,638
+185.4%
0.00%
Q4 2021$451,000
-45.1%
170,184
-24.7%
0.00%
Q3 2021$821,000
-20.9%
226,099
-5.5%
0.00%
-100.0%
Q2 2021$1,038,000
+33.4%
239,275
+5.2%
0.00%
Q1 2021$778,000
+100.5%
227,399
+105.2%
0.00%
Q4 2020$388,000
+52.8%
110,819
+4.7%
0.00%
Q3 2020$254,000
+19.2%
105,862
-8.9%
0.00%
Q2 2020$213,000
+55.5%
116,172
+32.2%
0.00%
Q1 2020$137,000
-70.2%
87,874
-59.0%
0.00%
Q4 2019$459,000
+40.8%
214,329
+22.8%
0.00%
Q3 2019$326,000
-24.4%
174,587
+5.6%
0.00%
Q2 2019$431,000
+902.3%
165,251
+887.5%
0.00%
Q1 2019$43,000
-20.4%
16,735
-29.2%
0.00%
Q4 2018$54,000
-73.7%
23,633
-63.0%
0.00%
Q3 2018$205,000
+3.0%
63,948
-9.2%
0.00%
Q2 2018$199,000
+87.7%
70,452
+135.9%
0.00%
Q1 2018$106,000
+21.8%
29,869
+33.1%
0.00%
Q4 2017$87,000
+38.1%
22,440
-10.1%
0.00%
Q3 2017$63,000
-22.2%
24,953
-16.1%
0.00%
Q2 2017$81,000
-20.6%
29,728
-3.5%
0.00%
Q1 2017$102,000
+54.5%
30,815
+11.3%
0.00%
Q4 2016$66,000
-80.4%
27,697
-69.7%
0.00%
-100.0%
Q3 2016$336,000
+16.7%
91,459
-29.1%
0.00%
Q2 2016$288,000
+9.9%
129,067
+2.6%
0.00%
Q1 2016$262,000
-33.2%
125,768
-2.9%
0.00%
-100.0%
Q4 2015$392,000
+27.3%
129,498
+3.9%
0.00%0.0%
Q3 2015$308,000
+14.5%
124,607
+48.8%
0.00%0.0%
Q2 2015$269,000
+2.3%
83,733
+13.7%
0.00%0.0%
Q1 2015$263,000
+64.4%
73,636
+4.4%
0.00%
Q4 2014$160,000
+83.9%
70,559
+57.8%
0.00%
Q3 2014$87,000
-66.7%
44,723
-37.7%
0.00%
-100.0%
Q2 2014$261,000
-22.1%
71,767
-16.9%
0.00%0.0%
Q1 2014$335,000
+51.6%
86,345
+11.4%
0.00%0.0%
Q4 2013$221,000
+55.6%
77,479
+95.3%
0.00%
Q3 2013$142,00039,6750.00%
Other shareholders
RIGEL PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 1,847,087$4,119,0003.26%
Sio Capital Management, LLC 1,333,696$2,974,0001.52%
Boxer Capital, LLC 700,000$1,561,0001.38%
Palo Alto Investors LP 5,386,534$12,012,0000.91%
ACUTA CAPITAL PARTNERS, LLC 747,748$1,667,0000.80%
SENZAR ASSET MANAGEMENT, LLC 1,443,003$3,217,897,0000.70%
Ghost Tree Capital, LLC 800,000$1,784,0000.52%
NEA Management Company, LLC 3,243,150$7,232,0000.38%
Rhenman & Partners Asset Management AB 850,000$1,896,0000.34%
Rock Springs Capital Management LP 1,750,000$3,903,0000.29%
View complete list of RIGEL PHARMACEUTICALS INC shareholders